Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regression

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF00391352PMID 2606928PMCID PMC12211569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of low-dose cyclophosphamide therapy on specific and nonspecific T cell-dependent immune responses of spleen cells from mice bearing large MOPC-315 plasmacytomas

  2004cited by this paper
• The Lyt phenotype of the T cells responsible for in vivo tumor rejection in syngeneic mice

  2004cited by this paper
• Specificity of the generation and expression of enhanced anti-plasmacytoma immunity by spleen cells from melphalan-treated MOPC-315 tumor bearers

  2004cited by this paper
• Augmentation of host antitumor immunity by low doses of cyclophosphamide and mafosfamide in two animal tumor models

  2004cited by this paper
• Regulation of natural killer activity

  2004cited by this paper
• Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice.

  1988cited by this paper
• Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.

  1988cited by this paper
• Oxazaphosphorine effects in L 5222 rat leukemia.

  1987cited by this paper
• Interactions of natural effector cells and prostaglandins in the control of metastasis.

  1987cited by this paper
• The effect of cyclophosphamide in vivo on the expression of lymphocyte markers, detected by monoclonal antibodies, in the rat.

  1986cited by this paper
• Correlation of circulating natural killer cell count with prognosis in large cell lymphoma

  1986cited by this paper
• Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice.

  1986cited by this paper
• Cyclophosphamide-mediated enhancement of antitumor immune potential of immunosuppressed spleen cells from mice bearing a large MOPC-315 tumor.

  1985cited by this paper
• Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines

  1985cited by this paper
• Effector immune mechanisms in cancer.

  1985cited by this paper
• Impairment of concanavalin A-inducible suppressor activity following administration of cyclophosphamide to patients with advanced cancer.

  1984cited by this paper
• Augmentation of the human immune response by cyclophosphamide.

  1982cited by this paper
• In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration

  1982cited by this paper
• Role of antitumor immunity in cyclophosphamide-induced rejection of subcutaneous nonpalpable MOPC-315 tumors.

  1982cited by this paper
• Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.

  1981cited by this paper
• Natural killer cells: their roles in defenses against disease.

  1981cited by this paper
• The Nude Mouse in Experimental and Clinical Research

  1979cited by this paper
• The beige mutation in the mouse selectively impairs natural killer cell function

  1979cited by this paper
• Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

  1977cited by this paper
• Enhancement of delayed hypersensitivity by depletion of suppressor T cells with cyclophosphamide in mice

  1976cited by this paper
• Enhancement by drugs of metastatic lung nodule formation after intravenous tumour cell injection

  1975cited by this paper
• Leukämie L 5222 des Rattenstammes BD IX. Eine durch Äthylnitrosoharnstoff induzierte monozytärmyeloische, transplantierbare Form für zytochemische und chemotherapeutische Studien

  1974cited by this paper
• [Leukemia L 5222 of the rat strain BD IX. An ethylnitrosourea-induced monocytic-myeloic transplantable form for cytochemical and chemotherapeutic studies].

  1974cited by this paper

• Investigation into the immunological effects of miltefosine, a new anticancer agent under development

  2005cites this paper
• Treatment of chemically induced autochthonous rat mammary and colorectal carcinomas with interleukin-2

  2005cites this paper
• Nonspecific immunostimulation with low doses of cyclophosphamide (LDCY), thymostimulin, and Echinacea purpurea extracts (echinacin) in patients with far advanced colorectal cancers: preliminary results.

  1992cites this paper